MAP2K7 and glaucoma: It is believed that metformin demonstrates neuroprotection against glutamate-induced excitotoxicity, which is seen in neurodegenerative disorders such as glaucoma and diabetic retinopathy by promoting retinal neuronal cell survival via the MEK/ERK signaling pathway [65,66,67,68].